AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33511392 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Slide Imaging (WSI)
Number of subjects: 171
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Antenatal Attachment Scale (MAAS)
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure avoidant adult attachment style
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal parental reflective functioning
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure anxious adult attachment style
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative disinterested MAAS style
Number of subjects: 78
Study 32941499 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively preoccupied MAAS style
Number of subjects: 78
Study 34836766 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 96
Study 33422019 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation procedures under MAR and MNAR assumptions
Number of subjects: 0
Study 35588754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed vaccine regimen (Rotavac-Rotasiil-Rotavac, Rotasiil-Rotavac-Rotasiil, Rotavac-Rotasiil-Rotasiil, Rotasiil-Rotavac-Rotavac)
Number of subjects: 1979
Study 35588754 — intervention group
Group type: COMPARATOR
Intervention: Single vaccine regimen (Rotavac-Rotavac-Rotavac, Rotasiil-Rotasiil-Rotasiil)
Number of subjects: 1979
Study 35588754 — intervention group
Group type: COMPARATOR
Intervention: Single vaccine regimen
Number of subjects: 1979
Study 35588754 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed vaccine regimen
Number of subjects: 1979
Study 33713202 — intervention group
Group type: EXPERIMENTAL
Intervention: SAMGvent
Number of subjects: 17
Study 33713202 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 17
Study 35788416 — intervention group
Group type: EXPERIMENTAL
Intervention: SC CAS+IMD 1200 mg
Number of subjects: 969
Study 35788416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 969
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Naomaitai Capsules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaoshuan Changrong Capsules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Angong Niuhuang Pills
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Yangxue Qingnao Granules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Danshen Dripping Pills
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoxintong Capsules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoxueshu Oral Liquid
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuyu Tongmai Capsules
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Yinxingye Tablets
Number of subjects: 52
Study 32627500 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Danshen Tablets
Number of subjects: 52
Study 33779002 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)-ibuprofen (S-IBU)
Number of subjects: 16
Study 33779002 — intervention group
Group type: EXPERIMENTAL
Intervention: R(−)-ibuprofen (R-IBU)
Number of subjects: 16
Study 32606092 — intervention group
Group type: EXPERIMENTAL
Intervention: Public sector
Number of subjects: 2232
Study 32606092 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach sector
Number of subjects: 2232
Study 33917584 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot reduction (SR) training
Number of subjects: 14
Study 33917584 — intervention group
Group type: COMPARATOR
Intervention: Traditional resistance training (RT)
Number of subjects: 14
Study 32210567 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Psychoeducation Programme (MBPP)
Number of subjects: 46
Study 32210567 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 46
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole + Mirena + Conservative Surgery (CS)
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole + Mirena + transvaginal ultrasound-guided puncture-aspiration (TUGPA)
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirena + Conservative Surgery (CS)
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirena + TUGPA
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirena + Anastrozole
Number of subjects: 31
Study 34016111 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirena (without Anastrozole)
Number of subjects: 31
Study 34016111 — intervention group
Group type: COMPARATOR
Intervention: Control (TUGPA)
Number of subjects: 31
Study 34017999 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 33
Study 34017999 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 33
Study 34017999 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 33
Study 32658077 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant Stereotactic Body Radiation Therapy (SBRT) - 33 Gy in 5 fractions to gross tumor plus abutting vessel, with or without 25 Gy in 5 fractions to pancreatic head/body and celiac/superior mesenteric artery.
Number of subjects: 43
Study 32658077 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated Chemoradiation - 50.4 Gy in 28 fractions to gross tumor, superior mesenteric/celiac arteries, and enlarged lymph nodes with concurrent bolus 5‐FU, leucovorin, oxaliplatin, irinotecan or gemcitabine/nab‐paclitaxel.
Number of subjects: 43
Study 32658077 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 43
Study 32658077 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated Chemoradiation
Number of subjects: 43
Study 34390300 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1200 mg/day)
Number of subjects: 22
Study 34390300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 33332574 — intervention group
Group type: EXPERIMENTAL
Intervention: Fumaric acid esters (FAE)
Number of subjects: 134
Study 33332574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 35133468 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg twice daily for 3 months
Number of subjects: 74
Study 35133468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 34658960 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based, multi-domain cognitive training with gamified elements together with treatment as usual (TAU)
Number of subjects: 60
Study 34658960 — intervention group
Group type: COMPARATOR
Intervention: Sham version of the same cognitive training together with TAU
Number of subjects: 60
Study 34658960 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based, multi-domain cognitive training with gamified elements
Number of subjects: 60
Study 34658960 — intervention group
Group type: COMPARATOR
Intervention: Sham version of the same cognitive training
Number of subjects: 60
Study 32751515 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame intervention for 24 weeks
Number of subjects: 25
Study 32751515 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 25
Study 35362188 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid plus glycyrrhizin (48-week stepwise dose reduction of methylprednisolone plus glycyrrhizin)
Number of subjects: 80
Study 35362188 — intervention group
Group type: COMPARATOR
Intervention: Glycyrrhizin alone (control group)
Number of subjects: 80
Study 35362188 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid plus glycyrrhizin
Number of subjects: 80
Study 33676969 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 SC every 2 weeks (q2w) from W6 to W54
Number of subjects: 131
Study 33676969 — intervention group
Group type: COMPARATOR
Intervention: CT-P13 IV every 8 weeks from W6 to W22
Number of subjects: 131
Study 33676969 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 SC after switching from CT-P13 IV at W30/W54
Number of subjects: 131
Study 33676969 — intervention group
Group type: COMPARATOR
Intervention: CT-P13 IV after switching to CT-P13 SC at W30/W54
Number of subjects: 131
Study 33676969 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 SC and CT-P13 IV
Number of subjects: 131
Study 32788280 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐percentage point increase in HbA1c
Number of subjects: 0
Study 35786525 — intervention group
Group type: EXPERIMENTAL
Intervention: BLSFE (Bone Window Repositioning)
Number of subjects: 26
Study 35786525 — intervention group
Group type: COMPARATOR
Intervention: LSFE (Lateral Sinus Floor Elevation without Bone Window Repositioning)
Number of subjects: 26
Study 34408034 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive deviance intervention (clinic-based and telephone-based counselling, 1-day participatory workshop)
Number of subjects: 960
Study 34408034 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 960
Study 32438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring (daily body weight measurement, daily recording of HF symptoms, and personalised education)
Number of subjects: 937
Study 32438483 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 937
Study 32438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 937
Study 32438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring in NYHA class III or IV HF
Number of subjects: 937
Study 32438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring in socially isolated patients
Number of subjects: 937
Study 32438483 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring in patients ≥70% adherent to body weight measurement
Number of subjects: 937
Study 36335552 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal cannabis (MC) as a prescription-only medication
Number of subjects: 48
Study 36335552 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttrial access to MC
Number of subjects: 48
Study 36335552 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative pathways to access MC or reduce prescribed dosage
Number of subjects: 48
Study 36335552 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative insights from interviews
Number of subjects: 48
Study 36335552 — intervention group
Group type: EXPERIMENTAL
Intervention: Calls for subsidisation
Number of subjects: 48
Study 33502078 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide 1.8 mg/day
Number of subjects: 14
Study 33559134 — intervention group
Group type: EXPERIMENTAL
Intervention: Pine bark extract (PE) supplementation (25 mg or 50 mg)
Number of subjects: 20
Study 33559134 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 20
Study 33893778 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Head Impulse Test (vHIT) assessment
Number of subjects: 28
Study 33893778 — intervention group
Group type: COMPARATOR
Intervention: Control group (age and gender-matched unaffected individuals)
Number of subjects: 28
Study 35302210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 1.0 mg/kg (K1 group)
Number of subjects: 51
Study 35302210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 2.0 mg/kg (K2 group)
Number of subjects: 51
Study 32628250 — intervention group
Group type: COMPARATOR
Intervention: Scheduled posthospitalization follow-up visit (n = 151)
Number of subjects: 304
Study 32628250 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed posthospitalization follow-up visit (n = 153)
Number of subjects: 304
Study 36193903 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week tele-exercise training program (3 sessions/week, 30 min/session, weekly remote monitoring)
Number of subjects: 83
Study 36193903 — intervention group
Group type: COMPARATOR
Intervention: Usual care only (Control Group)
Number of subjects: 83
Study 33812203 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Electrical Stimulation (TES) targeting anterior limbic areas (0.5 mA)
Number of subjects: 13
Study 33812203 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (placebo)
Number of subjects: 13
Study 33036155 — intervention group
Group type: EXPERIMENTAL
Intervention: Stevia group (n = 14)
Number of subjects: 28
Study 33036155 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study 35294608 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy diet (3.3 servings per day of low-fat milk, yogurt, and cheese)
Number of subjects: 72
Study 35294608 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-fat dairy diet (3.3 servings per day of full-fat milk, yogurt, and cheese)
Number of subjects: 72
Study 35294608 — intervention group
Group type: COMPARATOR
Intervention: Limited dairy diet (3 servings of nonfat milk per week)
Number of subjects: 72
Study 616787628 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM‐CSF
Number of subjects: 95
Study 35835067 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented vision (AV, using interactive color overlays)
Number of subjects: 48
Study 35835067 — intervention group
Group type: COMPARATOR
Intervention: Black-and-white textbook-like illustrations (control)
Number of subjects: 48
Study 34032504 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Androgen Deprivation Therapy (IADT)
Number of subjects: 8544
Study 33947770 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical carotid stenting
Number of subjects: 115
Study 33947770 — intervention group
Group type: COMPARATOR
Intervention: No cervical carotid stenting
Number of subjects: 115
Study 33947770 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem occlusions
Number of subjects: 115
Study 34398347 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq™
Number of subjects: 79
Study 34398347 — intervention group
Group type: EXPERIMENTAL
Intervention: KingVision™
Number of subjects: 79
Study 34398347 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AWS200™
Number of subjects: 79
Study 34398347 — intervention group
Group type: EXPERIMENTAL
Intervention: VividTrac VT‐A100™
Number of subjects: 79
Study 34398347 — intervention group
Group type: COMPARATOR
Intervention: Direct Macintosh laryngoscopy
Number of subjects: 79
Study 36067985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (education on nutrition, oral hygiene, and child stimulation)
Number of subjects: 357
Study 36067985 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 357
Study 36067985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 357
Study 36067985 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 357
Study 33245949 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 Gy boost after breast conserving surgery and whole breast radiation (50 Gy)
Number of subjects: 2421
Study 33245949 — intervention group
Group type: EXPERIMENTAL
Intervention: 26 Gy boost after breast conserving surgery and whole breast radiation (50 Gy)
Number of subjects: 2421
Study 33245949 — intervention group
Group type: EXPERIMENTAL
Intervention: Cases (patients who developed a LR)
Number of subjects: 2421
Study 33245949 — intervention group
Group type: COMPARATOR
Intervention: Controls (patients free of recurrence)
Number of subjects: 2421
Study 33245949 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurring tumors
Number of subjects: 2421
Study 35775631 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin treatment (200 mg twice daily for 6 weeks)
Number of subjects: 37
Study 35775631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 35775631 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin treatment
Number of subjects: 37
Study 32017242 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibiofemoral joint shape
Number of subjects: 119
Study 35186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine + SAPB
Number of subjects: 200
Study 35186237 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 34620153 — intervention group
Group type: EXPERIMENTAL
Intervention: Silybum marianum ointment
Number of subjects: 87
Study 34620153 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 87
Study 34315096 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-visiting intervention
Number of subjects: 1238
Study 34315096 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1238
Study 34315096 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal depressed mood patterns
Number of subjects: 1238
Study 34315096 — intervention group
Group type: EXPERIMENTAL
Intervention: Never depressed mothers
Number of subjects: 1238
Study 34315096 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent depressed mood
Number of subjects: 1238
Study 32603380 — intervention group
Group type: EXPERIMENTAL
Intervention: bCPAP
Number of subjects: 48
Study 32603380 — intervention group
Group type: COMPARATOR
Intervention: Oxygen therapy
Number of subjects: 48
Study 35446936 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST)
Number of subjects: 98
Study 35446936 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone
Number of subjects: 98
Study 35446936 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST) in SAA
Number of subjects: 98
Study 35446936 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone in SAA
Number of subjects: 98
Study 35446936 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltrombopag (ELTR) combined with immunosuppressive therapy (IST) in vSAA
Number of subjects: 98
Study 35446936 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) alone in vSAA
Number of subjects: 98
Study 35446936 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial ELTR(−) patients who crossed over to ELTR
Number of subjects: 98
Study 35446936 — intervention group
Group type: COMPARATOR
Intervention: Initial ELTR(+) patients
Number of subjects: 98
Study 33462752 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg research formulation)
Number of subjects: 0
Study 33462752 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib (100-400 mg/m2, and 600-800 mg) once daily with food
Number of subjects: 0
Study 33462752 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg single oral dose)
Number of subjects: 0
Study 33462752 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib (600 mg single doses, fasted state)
Number of subjects: 0
Study 33462752 — intervention group
Group type: EXPERIMENTAL
Intervention: Entrectinib (marketed formulation in fed and fasted states)
Number of subjects: 0
Study 32460816 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NCT) for 24 weeks
Number of subjects: 187
Study 32460816 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant endocrine therapy (NET) with goserelin and tamoxifen for 24 weeks
Number of subjects: 187
Study 33271040 — intervention group
Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 122
Study 34562764 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding with fine diamond bur (46 μm)
Number of subjects: 10
Study 34562764 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding with fine diamond bur followed by polishing with 2 tips (finisher and polisher)
Number of subjects: 10
Study 34562764 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding with extrafine diamond bur (30 μm)
Number of subjects: 10
Study 34562764 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding with extrafine diamond bur followed by polishing
Number of subjects: 10
Study 34562764 — intervention group
Group type: COMPARATOR
Intervention: Control - No adjustment
Number of subjects: 10
Study 32450154 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive care plus immunosuppression
Number of subjects: 149
Study 32450154 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 149
Study 35201916 — intervention group
Group type: EXPERIMENTAL
Intervention: CYCL
Number of subjects: 13
Study 35201916 — intervention group
Group type: EXPERIMENTAL
Intervention: OCCL
Number of subjects: 13
Study 35201916 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 13
Study 34763071 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin degludec (IDeg)
Number of subjects: 52
Study 34763071 — intervention group
Group type: COMPARATOR
Intervention: Continuous subcutaneous insulin infusion (CSII) with aspart
Number of subjects: 52
Study 33612519 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational stress
Number of subjects: 200
Study 32256955 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha Lipoic Acid (ALA) 1200 mg (two 600 mg capsules/day)
Number of subjects: 70
Study 32256955 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two maltodextrin capsules/day)
Number of subjects: 70
Study 35880282 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) of quintuple needling combined with adductor relaxation method
Number of subjects: 80
Study 35880282 — intervention group
Group type: COMPARATOR
Intervention: Adductor relaxation method
Number of subjects: 80
Study 32356465 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide plus salvage radiotherapy (SRT)
Number of subjects: 202
Study 32356465 — intervention group
Group type: COMPARATOR
Intervention: Androgen‐deprivation therapy with a luteinizing hormone‐releasing hormone agonist or antagonist plus SRT
Number of subjects: 202